Nasdaq · CIK 0001356576
SUPN SUPERNUS PHARMACEUTICALS, INC.
Insider trading from SEC Form 4. Last filing Aug 14, 2026. Close $42.67 on Oct 9, 2026, +3% from the 52-week low and -25% from the high.
In brief
SUPERNUS PHARMACEUTICALS, INC. (SUPN) has 120 SEC Form 4 filings on file from 10 insiders, the latest filed on Aug 14, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
44 open-market trades have been scored at SUPN. The newest: Padmanabh P. Bhatt (Sr. VP of IP, CSO) sold $5.4M of stock on Mar 16, 2026, filed Mar 18, 2026, scored 40 (moderate), under a 10b5-1 plan. The largest of the 44 shown: Jack A. Khattar (President, CEO) sold $5.9M on Aug 6, 2025, scored 35 (weak), under a 10b5-1 plan. 6 insiders sold within 14 days of each other around Mar 16, 2026.
1 member of Congress has disclosed 4 trades in SUPN under the STOCK Act. 25 Form 144 notices of planned sales are on file, the latest filed Mar 17, 2026.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
10
with a Form 4 at this company
Price and insider trades, last year
SUPNOct 9, 2026 · close 42.67
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at SUPERNUS PHARMACEUTICALS, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | Padmanabh P. Bhatt Sr. VP of IP, CSO sell | $5.4M 107,250 shares | -160% | +66% from low-12% from high | |
| 43Moderate | Frederick M. Hudson director sell | $272k 5,369 shares | -8% | +67% from low-11% from high | |
| 45Moderate | Jack A. Khattar President, CEO sell | $1.8M 35,000 shares | -4% | +65% from low-12% from high | |
| 53Moderate | William Todd Horich SVP, Commercial Operations sell | $484k 8,877 shares | -100% | +79% from low-5% from high | |
| 24Weak | Frank Mottola SVP, Chief Tech. Ops. Officer sell | $87k 1,623 shares | -8% | +79% from low-5% from high | |
| 50Moderate | Georges Gemayel director sell | $1.0M 18,787 shares | -49% | +79% from low-5% from high | |
| 21Weak | Bethany Sensenig director sell | $228k 4,475 shares | -100% | +70% from low-10% from high | |
| 33Weak | Frank Mottola SVP, Chief Tech. Ops. Officer sell | $1.0M 20,000 shares | -98% | +70% from low-10% from high | |
| 13Weak | Padmanabh P. Bhatt Sr. VP of IP, CSO sell | $32k 710 shares | -5% | +63% from low-14% from high | |
| 23Weak | Jack A. Khattar President, CEO sell | $3.0M 59,900 shares | -5% | +63% from low0% from high | |
| 33Weak | Charles W Newhall III director sell | $1.3M 25,000 shares | -19% | +63% from low0% from high | |
| 7Weak | Jack A. Khattar President, CEO sell | $92k 1,904 shares | -0% | +58% from low-0% from high | |
| 23Weak | Jack A. Khattar President, CEO sell | $1.9M 40,173 shares | -3% | +59% from low0% from high | |
| 14Weak | Jack A. Khattar President, CEO sell | $414k 8,588 shares | -1% | +58% from low0% from high | |
| 16Weak | Jack A. Khattar President, CEO sell | $491k 10,235 shares | -1% | +57% from low0% from high | |
| 23Weak | Jack A. Khattar President, CEO sell | $1.4M 29,513 shares | -3% | +56% from low-0% from high | |
| 20Weak | Jack A. Khattar President, CEO sell | $780k 16,587 shares | -1% | +57% from low0% from high | |
| 26Weak | Frank Mottola SVP, Chief Tech. Ops. Officer sell | $229k 5,000 shares | -24% | +52% from low-3% from high | |
| 19Weak | Jack A. Khattar President, CEO sell | $293k 6,322 shares | -1% | +53% from low-0% from high | |
| 30Weak | Jack A. Khattar President, CEO sell | $2.6M 55,578 shares | -5% | +54% from low0% from high | |
| 30Weak | Jack A. Khattar President, CEO sell | $1.6M 34,800 shares | -3% | +51% from low0% from high | |
| 21Weak | Charles W Newhall III director sell | $161k 3,588 shares | -3% | +51% from low0% from high | |
| 11Weak | Jack A. Khattar President, CEO sell | $45k 1,000 shares | -0% | +48% from low-1% from high | |
| 45Moderate | Frank Mottola SVP, Quality, GMP, Ops, IT sell | $623k 14,000 shares | -47% | +48% from low-1% from high | |
| 16Weak | Charles W Newhall III director sell | $45k 1,000 shares | -1% | +48% from low-1% from high | |
| 75Notable | Timothy C Dec Senior Vice-President & CFO sell | $524k 11,780 shares | -90% | +50% from low0% from high | |
| 13Weak | Jack A. Khattar President, CEO sell | $68k 1,500 shares | -0% | +50% from low0% from high | |
| 18Weak | Charles W Newhall III director sell | $64k 1,412 shares | -1% | +50% from low0% from high | |
| 49Moderate | Frederick M. Hudson director sell | $315k 7,457 shares | -14% | +41% from low-1% from high | |
| 43Moderate | Bethany Sensenig director sell | $227k 5,369 shares | -100% | +41% from low-1% from high | |
| 35Weak | Jack A. Khattar President, CEO sell | $5.9M 140,000 shares | -13% | +42% from low0% from high | |
| 6Weak | Padmanabh P. Bhatt Sr. VP of IP, CSO sell | $376k 9,477 shares | -48% | - | |
| 1Weak | Padmanabh P. Bhatt Sr. VP of IP, CSO sell | $130k 3,273 shares | -26% | - | |
| 22Weak | Padmanabh P. Bhatt Sr. VP of IP, CSO sell | $788k 21,495 shares | -117% | - | |
| 41Moderate | Georges Gemayel director sell | $392k 10,787 shares | -45% | - | |
| 49Moderate | Frederick M. Hudson director sell | $316k 8,722 shares | -23% | - | |
| 55Moderate | Jack A. Khattar President, CEO sell | $4.5M 125,000 shares | -12% | - | |
| 31Weak | Charles W Newhall III director sell | $388k 10,700 shares | -8% | - | |
| 53Moderate | Georges Gemayel director sell | $520k 14,213 shares | -52% | - | |
| 55Moderate | Jack A. Khattar President, CEO sell | $4.6M 125,000 shares | -12% | - | |
| 54Moderate | Frank Mottola SVP, Quality, GMP, Ops, IT sell | $555k 15,000 shares | -65% | - | |
| 23Weak | Charles W Newhall III director sell | $70k 2,500 shares | -2% | +23% from low-34% from high | |
| 33Weak | Frederick M. Hudson director sell | $259k 9,093 shares | -21% | +26% from low-32% from high | |
| 25Weak | Frank Mottola SVP, Quality, GMP, Ops, IT sell | $31k 1,110 shares | -16% | +23% from low-33% from high |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 17, 2026 | PADMANABH P BHATT Officer | 57,250 0.10% of outstanding | $2.9M | Mar 17, 2026 | $2.5M |
| Mar 16, 2026 | PADMANABH P BHATT Officer | 50,000 0.00% of outstanding | $2.5M | Mar 16, 2026 | none |
| Mar 13, 2026 | THE KBT TRUST U/A DTD 12/30/2010 Director, Officer | 35,000 0.06% of outstanding | $1.8M | Mar 13, 2026 | none |
| Mar 12, 2026 | FREDERICK M HUDSON Director | 5,369 0.01% of outstanding | $272k | Mar 12, 2026 | none |
| Mar 10, 2026 | WILLIAM TODD HORICH Officer | 4,439 0.01% of outstanding | $244k | Mar 10, 2026 | $240k |
| Mar 9, 2026 | WILLIAM TODD HORICH Officer | 4,438 0.01% of outstanding | $240k | Mar 9, 2026 | none |
| Mar 9, 2026 | FRANK MOTTOLA Officer | 1,623 0.00% of outstanding | $87k | Mar 9, 2026 | none |
| Mar 6, 2026 | GEORGES GEMAYEL Director | 8,787 0.02% of outstanding | $466k | Mar 6, 2026 | $537k |
| Mar 5, 2026 | GEORGES GEMAYEL Director | 10,000 0.02% of outstanding | $537k | Mar 5, 2026 | none |
| Feb 19, 2026 | BETHANY SENSENIG Director | 4,475 0.01% of outstanding | $225k | Feb 19, 2026 | none |
| Dec 19, 2025 | FRANK MOTTOLA Officer | 20,000 0.03% of outstanding | $986k | Dec 19, 2025 | none |
| Oct 9, 2025 | JACK A. KHATTAR Director, Officer | 59,900 0.11% of outstanding | $2.9M | Oct 9, 2025 | $16M |
| Oct 9, 2025 | CHARLES NEWHALL Director | 25,000 0.04% of outstanding | $1.2M | Oct 9, 2025 | $270k |
| Oct 2, 2025 | JACK A. KHATTAR Director, Officer | 1,904 0.00% of outstanding | $91k | Oct 2, 2025 | $15M |
| Oct 1, 2025 | JACK A. KHATTAR Director, Officer | 40,173 0.07% of outstanding | $1.9M | Oct 1, 2025 | $13M |
| Sep 30, 2025 | JACK A. KHATTAR Director, Officer | 8,588 0.02% of outstanding | $409k | Sep 30, 2025 | $13M |
| Sep 29, 2025 | JACK A. KHATTAR Director, Officer | 10,235 0.02% of outstanding | $481k | Sep 29, 2025 | $13M |
| Sep 23, 2025 | JACK A. KHATTAR Director, Officer | 29,513 0.05% of outstanding | $1.4M | Sep 23, 2025 | $11M |
| Sep 22, 2025 | JACK A KHATTAR Officer | 16,587 0.03% of outstanding | $764k | Sep 22, 2025 | $10M |
| Sep 12, 2025 | FRANK MOTTOLA Officer | 5,000 0.01% of outstanding | $229k | Sep 12, 2025 | $623k |
| Sep 8, 2025 | JACK A KHATTAR Officer | 6,322 0.01% of outstanding | $291k | Sep 8, 2025 | $10M |
| Sep 5, 2025 | JACK A KHATTAR Director, Officer | 55,578 0.10% of outstanding | $2.5M | Sep 5, 2025 | $7.6M |
| Aug 28, 2025 | JACK A KHATTAR Director, Officer | 24,150 0.04% of outstanding | $1.1M | Aug 28, 2025 | $6.5M |
| Aug 27, 2025 | JACK A KHATTAR Director, Officer | 10,650 0.02% of outstanding | $472k | Aug 27, 2025 | $6.0M |
| Aug 25, 2025 | JACK A KHATTAR Director, Officer | 1,000 0.00% of outstanding | $45k | Aug 25, 2025 | $6.0M |
Congressional trades
4 trades in SUPN disclosed by members of Congress under the STOCK Act. All congressional trades.
- Gilbert Ray Cisneros, Jr.House · D-CA · last Apr 7, 20263 bought
1 sold
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | SUPN Supernus Pharmaceuticals, Inc. - Common Stock | $1,001 to $15k | Mar 3 / Apr 7 35 days after the trade | Clerk |
Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | SUPN Supernus Pharmaceuticals, Inc. - Common Stock | $1,001 to $15k | Dec 11, 2025 / Jan 12 32 days after the trade | Clerk |
Gilbert Ray Cisneros, Jr. House · D-CA | Partial sale | SUPN Supernus Pharmaceuticals, Inc. - Common Stock | $1,001 to $15k | Oct 9, 2025 / Nov 18, 2025 40 days after the trade | Clerk |
Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | SUPN Supernus Pharmaceuticals, Inc. - Common Stock | $1,001 to $15k | Mar 24, 2025 / Apr 7, 2025 14 days after the trade | Clerk |
Transactions
The newest 50 of 384 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Frank Mottola SVP, Chief Tech. Ops. Officer | MOption exercise Common Stock | +1,650 | $0.00 | $0 | 20,341 | Aug 14, 2026 |
| Aug 12, 2026 | Jonathan Rubin SVP, Chief Medical Officer | MOption exercise Common Stock | +750 | $0.00 | $0 | 14,342 | Aug 14, 2026 |
| Aug 12, 2026 | Jack A. Khattar President, CEO | MOption exercise Common Stock | +29,849 | $0.00 | $0 | 1,270,993 | Aug 14, 2026 |
| Aug 12, 2026 | Timothy C Dec Senior Vice-President & CFO | MOption exercise Common Stock | +1,250 | $0.00 | $0 | 9,733 | Aug 14, 2026 |
| Aug 12, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | MOption exercise Common Stock | +2,500 | $0.00 | $0 | 19,795 | Aug 14, 2026 |
| Aug 12, 2026 | Frank Mottola SVP, Chief Tech. Ops. Officer | FTax withholding Common Stock | -797 | $46.57 | $37k | 19,544 | Aug 14, 2026 |
| Aug 12, 2026 | Jack A. Khattar President, CEO | FTax withholding Common Stock | -12,642 | $46.57 | $589k | 1,258,351 | Aug 14, 2026 |
| Aug 12, 2026 | Timothy C Dec Senior Vice-President & CFO | FTax withholding Common Stock | -604 | $46.57 | $28k | 9,129 | Aug 14, 2026 |
| Aug 12, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | FTax withholding Common Stock | -1,158 | $46.57 | $54k | 18,637 | Aug 14, 2026 |
| Aug 12, 2026 | Jonathan Rubin SVP, Chief Medical Officer | FTax withholding Common Stock | -363 | $46.57 | $17k | 13,979 | Aug 14, 2026 |
| Aug 12, 2026 | Frank Mottola SVP, Chief Tech. Ops. Officer | MOption exercise Performance Share Unitderivative | -1,650 | $0.00 | $0 | 0 | Aug 14, 2026 |
| Aug 12, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | MOption exercise Performance Share Unitderivative | -2,500 | $0.00 | $0 | 0 | Aug 14, 2026 |
| Aug 12, 2026 | Timothy C Dec Senior Vice-President & CFO | MOption exercise Performance Share Unitderivative | -1,250 | $0.00 | $0 | 0 | Aug 14, 2026 |
| Aug 12, 2026 | Jonathan Rubin SVP, Chief Medical Officer | MOption exercise Performance Share Unitderivative | -750 | $0.00 | $0 | 0 | Aug 14, 2026 |
| Aug 12, 2026 | Jack A. Khattar President, CEO | MOption exercise Performance Share Unitderivative | -29,849 | $0.00 | $0 | 0 | Aug 14, 2026 |
| Jul 29, 2026 | Frank Mottola SVP, Chief Tech. Ops. Officer | AGrant or award Performance Share Unitderivative | +1,650 | $0.00 | $0 | 1,650 | Jul 31, 2026 |
| Jul 29, 2026 | Timothy C Dec Senior Vice-President & CFO | AGrant or award Performance Share Unitderivative | +1,250 | $0.00 | $0 | 1,250 | Jul 31, 2026 |
| Jul 29, 2026 | Jonathan Rubin SVP, Chief Medical Officer | AGrant or award Performance Share Unitderivative | +750 | $0.00 | $0 | 750 | Jul 31, 2026 |
| Jul 29, 2026 | Jack A. Khattar President, CEO | AGrant or award Performance Share Unitderivative | +29,849 | $0.00 | $0 | 29,849 | Jul 31, 2026 |
| Jul 29, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | AGrant or award Performance Share Unitderivative | +2,500 | $0.00 | $0 | 2,500 | Jul 31, 2026 |
| Mar 16, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | MOption exercise Common Stock10b5-1 | +22,750 | $36.75 | $836k | 39,794 | Mar 18, 2026 |
| Mar 16, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | MOption exercise Common Stock10b5-1 | +4,250 | $29.61 | $126k | 44,044 | Mar 18, 2026 |
| Mar 16, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | MOption exercise Common Stock10b5-1 | +18,000 | $32.20 | $580k | 62,044 | Mar 18, 2026 |
| Mar 16, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | MOption exercise Common Stock10b5-1 | +5,000 | $27.94 | $140k | 67,044 | Mar 18, 2026 |
| Mar 16, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | SOpen-market sale Common Stock10b5-1 | -34,114 | $50.18 | $1.7M | 32,930 | Mar 18, 2026 |
| Mar 16, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | SOpen-market sale Common Stock10b5-1 | -15,886 | $50.49 | $802k | 17,044 | Mar 18, 2026 |
| Mar 17, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | MOption exercise Common Stock10b5-1 | +22,750 | $39.40 | $896k | 39,794 | Mar 18, 2026 |
| Mar 17, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | MOption exercise Common Stock10b5-1 | +12,250 | $36.75 | $450k | 52,044 | Mar 18, 2026 |
| Mar 17, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | MOption exercise Common Stock10b5-1 | +15,000 | $38.60 | $579k | 67,044 | Mar 18, 2026 |
| Mar 17, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | SOpen-market sale Common Stock10b5-1 | -27,710 | $49.95 | $1.4M | 39,334 | Mar 18, 2026 |
| Mar 17, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | SOpen-market sale Common Stock10b5-1 | -22,290 | $50.73 | $1.1M | 17,044 | Mar 18, 2026 |
| Mar 18, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | MOption exercise Common Stock10b5-1 | +7,250 | $39.40 | $286k | 24,294 | Mar 18, 2026 |
| Mar 18, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | SOpen-market sale Common Stock10b5-1 | -6,838 | $49.55 | $339k | 17,456 | Mar 18, 2026 |
| Mar 18, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | SOpen-market sale Common Stock10b5-1 | -412 | $50.48 | $21k | 17,044 | Mar 18, 2026 |
| Mar 16, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -22,750 | $0.00 | $0 | 12,250 | Mar 18, 2026 |
| Mar 16, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -4,250 | $0.00 | $0 | 0 | Mar 18, 2026 |
| Mar 16, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -18,000 | $0.00 | $0 | 0 | Mar 18, 2026 |
| Mar 16, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -5,000 | $0.00 | $0 | 15,000 | Mar 18, 2026 |
| Mar 17, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -22,750 | $0.00 | $0 | 7,250 | Mar 18, 2026 |
| Mar 17, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -12,250 | $0.00 | $0 | 0 | Mar 18, 2026 |
| Mar 17, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 5,000 | Mar 18, 2026 |
| Mar 18, 2026 | Padmanabh P. Bhatt Sr. VP of IP, CSO | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -7,250 | $0.00 | $0 | 0 | Mar 18, 2026 |
| Mar 13, 2026 | Jack A. Khattar President, CEO | JOther Common Stock10b5-1 | +12,500 | - | - | 1,241,144 | Mar 16, 2026 |
| Mar 12, 2026 | Frederick M. Hudson director | SOpen-market sale Common Stock | -5,369 | $50.61 | $272k | 60,413 | Mar 16, 2026 |
| Mar 13, 2026 | Jack A. Khattar President, CEO | JOther Common Stockindirect: By the KBT Trust10b5-1 | -12,500 | - | - | 993,100 | Mar 16, 2026 |
| Mar 13, 2026 | Jack A. Khattar President, CEO | SOpen-market sale Common Stockindirect: By the KBT Trust10b5-1 | -24,138 | $50.09 | $1.2M | 968,962 | Mar 16, 2026 |
| Mar 13, 2026 | Jack A. Khattar President, CEO | SOpen-market sale Common Stockindirect: By the KBT Trust10b5-1 | -10,742 | $51.00 | $548k | 958,220 | Mar 16, 2026 |
| Mar 13, 2026 | Jack A. Khattar President, CEO | SOpen-market sale Common Stockindirect: By the KBT Trust10b5-1 | -120 | $51.75 | $6,210 | 958,100 | Mar 16, 2026 |
| Mar 6, 2026 | William Todd Horich SVP, Commercial Operations | MOption exercise Common Stock | +2,625 | $0.00 | $0 | 7,457 | Mar 10, 2026 |
| Mar 6, 2026 | Timothy C Dec Senior Vice-President & CFO | MOption exercise Common Stock | +3,000 | $0.00 | $0 | 8,115 | Mar 10, 2026 |
50 of 384 rows shown.
Insiders
Everyone who has filed a Form 4 here.
- Padmanabh P. BhattSr. VP of IP, CSO
- Timothy C DecSenior Vice-President & CFO
- Georges Gemayeldirector
- William Todd HorichSVP, Commercial Operations
- Frederick M. Hudsondirector
- Jack A. KhattarPresident, CEO
- Frank MottolaSVP, Quality, GMP, Ops, IT
- Charles W Newhall IIIdirector
- Jonathan RubinSr. VP, Chief Medical Officer
- Bethany Sensenigdirector
Questions about SUPN
Answered from the filings on this page, as of the latest one.
Are insiders buying SUPN?
No. In the last 90 days no insider at SUPERNUS PHARMACEUTICALS, INC. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade SUPN on the open market?
Padmanabh P. Bhatt (Sr. VP of IP, CSO) sold $5.4M of SUPN on Mar 16, 2026 and filed the Form 4 on Mar 18, 2026. InsiderTell scored 40 (moderate), under a 10b5-1 plan, with 6 insiders on the same side within 14 days.
How many insiders file Form 4 at SUPERNUS PHARMACEUTICALS, INC.?
10 people have filed a Form 4 at SUPERNUS PHARMACEUTICALS, INC., among them Padmanabh P. Bhatt (Sr. VP of IP, CSO), Timothy C Dec (Senior Vice-President & CFO), Georges Gemayel (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.